Potential eligibility for Aducanumab therapy in an Irish specialist cognitive service-Utilising cerebrospinal fluid biomarkers and appropriate use criteria.
International Journal of Geriatric Psychiatry（2022）
摘要
All patients in the combined cognitive clinic provide consent re willingness to be contacted re research.
更多查看译文
关键词
Aducanumab,Alzheimer's,anti-amyloid therapy,cognition,memory
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要